Masui Takashi, Uemura Hirokazu, Ota Ichiro, Kimura Takahiro, Nishikawa Daisuke, Yamanaka Toshiaki, Yane Katsunari, Kitahara Tadashi
Department of Otolaryngology-Head and Neck Surgery, Nara Medical University, Kashihara, Nara 634-8522, Japan.
Department of Otolaryngology, Kindai University School of Medicine, Nara Hospital, Ikoma, Nara 630-0293, Japan.
Mol Clin Oncol. 2021 Sep;15(3):183. doi: 10.3892/mco.2021.2345. Epub 2021 Jul 3.
Salivary gland carcinoma is a relatively rare disease of the head and neck. Although it frequently presents with distant metastases, few reports have been published on this subject. The present study investigated the prognosis of patients with distant metastases from salivary gland cancer. A total of 24 cases of salivary gland carcinoma with distant metastasis who were initially treated at the Department of Otolaryngology-Head and Neck Surgery of Nara Medical University during a 16-year period from August 2004 to July 2020 were included. The histopathological types included salivary duct carcinoma (8 cases), adenoid cystic carcinoma (6 cases), myoepithelial carcinoma (3 cases), Squamous cell carcinoma (2 cases), adenocarcinoma (2 cases), acinic cell carcinoma (2 cases) and mucoepidermoid carcinoma (1 case). A total of 18 patients had stage IV carcinoma, which represented the majority. Of all patients, ~80% developed distant metastases within 2 years of initial diagnosis. Survival rates after the appearance of distant metastases were 43.5% at 5 years and 14.5% at 10 years. The results of the current study revealed that no factors significantly influenced long-term prognosis after the development of distant metastases. In future, it may be necessary to re-examine these results in a larger sample size and standardise treatment methods as a result.
涎腺癌是一种相对罕见的头颈部疾病。尽管它经常出现远处转移,但关于这个主题的报道很少。本研究调查了涎腺癌远处转移患者的预后。纳入了2004年8月至2020年7月期间在奈良医科大学耳鼻咽喉头颈外科初治的24例涎腺癌远处转移患者。组织病理学类型包括涎腺导管癌(8例)、腺样囊性癌(6例)、肌上皮癌(3例)、鳞状细胞癌(2例)、腺癌(2例)、腺泡细胞癌(2例)和黏液表皮样癌(1例)。共有18例患者为IV期癌,占大多数。在所有患者中,约80%在初次诊断后2年内发生远处转移。远处转移出现后的5年生存率为43.5%,10年生存率为14.5%。本研究结果显示,远处转移发生后,没有因素对长期预后有显著影响。未来,可能有必要以更大的样本量重新审视这些结果,并因此规范治疗方法。